BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Anugayathri Jawahar, Beverly Gonzalez, Neelam Balasubramanian, William Adams, Ari Goldberg. Comparison of computed tomography hepatic steatosis criteria for identification of abnormal liver function and clinical risk factors, in incidentally noted fatty liverEuropean Journal of Gastroenterology & Hepatology 2020; 32(2): 216 doi: 10.1097/MEG.0000000000001502
2
Mark E. Lockhart, Andrew D. Smith. Fatty Liver Disease: Artificial Intelligence Takes on the ChallengeRadiology 2020; 295(2): 351 doi: 10.1148/radiol.2020200058
3
Louise J. M. Alferink, Nicole S. Erler, Robert J. de Knegt, Harry L. A. Janssen, Herold J. Metselaar, Sarwa Darwish Murad, Jessica C. Kiefte-de Jong. Adherence to a plant-based, high-fibre dietary pattern is related to regression of non-alcoholic fatty liver disease in an elderly populationEuropean Journal of Epidemiology 2020;  doi: 10.1007/s10654-020-00627-2
4
P.-Y. Brillet. Dépistage du cancer broncho-pulmonaire: les « big 3 » et les autresRevue des Maladies Respiratoires Actualités 2019; 11(2): 107 doi: 10.1016/S1877-1203(19)30041-2
5
Mercedes del Río-Moreno, Emilia Alors-Pérez, Sandra González-Rubio, Gustavo Ferrín, Oscar Reyes, Manuel Rodríguez-Perálvarez, Marina E Sánchez-Frías, Rafael Sánchez-Sánchez, Sebastián Ventura, José López-Miranda, Rhonda D Kineman, Manuel de la Mata, Justo P Castaño, Manuel D Gahete, Raúl M Luque. Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver DiseaseThe Journal of Clinical Endocrinology & Metabolism 2019; 104(8): 3389 doi: 10.1210/jc.2019-00021
6
Man Zhang. Imaging Biomarkers for Nonalcoholic Fatty Liver DiseaseAcademic Radiology 2019; 26(7): 869 doi: 10.1016/j.acra.2019.04.001
7
J.A. Weintraub, G. Lopez Mitnik, B.A. Dye. Oral Diseases Associated with Nonalcoholic Fatty Liver Disease in the United StatesJournal of Dental Research 2019; 98(11): 1219 doi: 10.1177/0022034519866442
8
Dominika Maciejewska, Joanna Palma, Karolina Dec, Karolina Skonieczna-Żydecka, Izabela Gutowska, Małgorzata Szczuko, Karolina Jakubczyk, Ewa Stachowska. Is the Fatty Acids Profile in Blood a Good Predictor of Liver Changes? Correlation of Fatty Acids Profile with Fatty Acids Content in the LiverDiagnostics 2019; 9(4): 197 doi: 10.3390/diagnostics9040197
9
Reham M. Gameaa, Nehad Hawash, Rehab Badawi, Sherief Abd-Elsalam, Gamal K. Kasem, El-Sayed A. Wasfy. Assessment of Hepatic Steatosis in Patients with Chronic Hepatitis B Using Fibroscan and its Relation to Insulin ResistanceThe Open Biomarkers Journal 2019; 9(1): 70 doi: 10.2174/1875318301909010070
10
Gerhard Nygaard. On a Novel, Simplified Model Framework Describing Ascorbic Acid Concentration Dynamics2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 2019; : 2880 doi: 10.1109/EMBC.2019.8857675
11
Javier Espíldora-Hernández, Tania Díaz-Antonio, Javier Baena-Espinar, Inmaculada Alonso-Calderón, José Rioja, Emilio Alba-Conejo, Pedro Valdivielso, Miguel-Ángel Sánchez-Chaparro. Subclinical Arteriosclerosis is Associated with Common Vascular Risk Factors in Long-Term Survivors of Testicular CancerJournal of Clinical Medicine 2020; 9(4): 971 doi: 10.3390/jcm9040971
12
Jiajia Yang, Liwu Lin, Ensheng Xue, Dengke Hong, Yan Yang, Meifang Xu, Zhikui Chen. Can Nonfibrotic Nonalcoholic Steatohepatitis Be Effectively Identified by Supersonic Shear Imaging?Analytical Cellular Pathology 2019; 2019: 1 doi: 10.1155/2019/2013674
13
Somaya Albhaisi, Arun J. Sanyal. Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to DatePharmaceutical Medicine 2019; 33(6): 451 doi: 10.1007/s40290-019-00305-z
14
Jeffrey Budd, Kenneth Cusi. Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know?The American Journal of Medicine 2020; 133(5): 536 doi: 10.1016/j.amjmed.2020.01.007
15
Zaki A. Sherif. Nonalcoholic Fatty Liver Disease - An Update2019;  doi: 10.5772/intechopen.85780
16
Fuad Jafarov, Eda Kaya, Alev Bakir, Fatih Eren, Yusuf Yilmaz. The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosisEuropean Journal of Gastroenterology & Hepatology 2020; 32(5): 642 doi: 10.1097/MEG.0000000000001573
17
Tasnim Alkayyali, Lubna Qutranji, Eda Kaya, Alev Bakir, Yusuf Yilmaz. Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver diseaseActa Diabetologica 2020; 57(5): 613 doi: 10.1007/s00592-019-01467-7
18
Zhen Huang, Lei‐Ming Wu, Jie‐Lei Zhang, Abdelkarim Sabri, Shou‐Jun Wang, Gui‐Jun Qin, Chang‐Qing Guo, Hong‐Tao Wen, Bin‐Bin Du, Dian‐Hong Zhang, Ling‐Yao Kong, Xin‐Yu Tian, Rui Yao, Ya‐Peng Li, Cui Liang, Peng‐Cheng Li, Zheng Wang, Jin‐Yan Guo, Ling Li, Jian‐Zeng Dong, Yan‐Zhou Zhang. Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal–Regulating Kinase 1 PathwaysHepatology 2019; 70(4): 1099 doi: 10.1002/hep.30597
19
Arinc Ozturk, Ramin Mohammadi, Theodore T. Pierce, Sagar Kamarthi, Manish Dhyani, Joseph R. Grajo, Kathleen E. Corey, Raymond T. Chung, Atul K. Bhan, Jagpreet Chhatwal, Anthony E. Samir. Diagnostic Accuracy of Shear Wave Elastography as a Non-invasive Biomarker of High-Risk Non-alcoholic Steatohepatitis in Patients with Non-alcoholic Fatty Liver DiseaseUltrasound in Medicine & Biology 2020; 46(4): 972 doi: 10.1016/j.ultrasmedbio.2019.12.020
20
Andrew J. Krentz, Pierre Bedossa. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease2019; : 245 doi: 10.1007/978-3-030-11748-1_10
21
Stefano Ballestri, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo, Giampiero Francica. A critical appraisal of the use of ultrasound in hepatic steatosisExpert Review of Gastroenterology & Hepatology 2019; 13(7): 667 doi: 10.1080/17474124.2019.1621164
22
A. P. Gonchar, V. A. Gombolevskij, A. B. Elizarov, N. S. Kulberg, V. G. Klyashtorny, V. Yu. Chernina, V. Yu. Bosin, S. P. Morozov. Liver density in routine and low-dose computed tomography: the effect of image noise on measurement accuracyMedical Visualization 2020; 24(1): 39 doi: 10.24835/1607-0763-2020-1-39-47
23
Niki Katsiki, Amalia Gastaldelli, Dimitri P. Mikhailidis. Predictive models with the use of omics and supervised machine learning to diagnose non-alcoholic fatty liver disease: A “non-invasive alternative” to liver biopsy?Metabolism 2019; 101: 154010 doi: 10.1016/j.metabol.2019.154010
24
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease researchWorld Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163
25
Ahmad Khonche, Hasan Fallah Huseini, Mahdi Gholamian, Reza Mohtashami, Farzaneh Nabati, Saeed Kianbakht. Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trialJournal of Ethnopharmacology 2019; 234: 106 doi: 10.1016/j.jep.2019.01.009
26
Nirmalya Sinha, Saptarshi Mukhopadhyay, Manabendra Sau. Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesityIndian Journal of Gastroenterology 2020; 39(1): 75 doi: 10.1007/s12664-020-01020-3